Big Gain For NovaBay Pharmaceuticals, Inc.
Mon, Nov 18, 2019 at 05:30 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) soared today at $0.66, representing a gain of 29.8%. On Fri, 15 Nov 19, NBY:NYSEMKT hit a New 2-Week Low of $0.51. The stock featured on our News Catalysts scanner on Fri, 08 Nov 19 at 03:16 AM. From Mon, 28 Oct 19, the stock recorded 35.71% Up Days and 40.00% Green Days
The stock spiked on Thu, 19 Sep 19 at $0.82 with a volume of 6M+.
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- Karuna Therapeutics, Inc. (KRTX:NASDAQ), 442.99%
- Hermitage Offshore Services Ltd. (PSV:NYSE), 55.14%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 34.55%
- Protalix BioTherapeutics, Inc. (PLX:NYSEMKT), 32.31%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 29.78%
- BiomX Inc. (PHGE:NYSEMKT), 29.2%
- Standard Diversified Inc. (SDI:NYSEMKT), 27.64%
- Advaxis, Inc. (ADXS:NASDAQ), 26.57%
- Waitr Holdings Inc. (WTRH:NASDAQ), 26.28%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 26.1%